ARXS ARXS
Company Profile ↓Company Overview
ARXS (ARXS) is a publicly traded company listed on with a market capitalization of $24.10B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 94.2% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.60B (+115.5% YoY); net profit $-49.83M.
- Trailing 12 Months Year-on-year growth — revenue +115.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 94.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 94.21% |
| 1 Year: | 115.49% |
Stock Price Performance
| 1 Year: | +53.81% |
| 6 Months: | - |
| 3 Months: | +68.08% |
| 1 Month: | +40.27% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)76.47 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 94.2% over 5 years.
- Generates positive free cash flow.
CONS
- RSI at 76 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 380.08M | 400.44M | 458.86M | 500.73M |
| Cost of Revenue | 217.17M | 202.83M | 224.01M | 238.13M |
| Gross Profit | 162.91M | 197.61M | 234.84M | 262.60M |
| Operating Expenses | 102.71M | 114.76M | 124.34M | 229.92M |
| Operating Income | 60.20M | 82.85M | 110.50M | 32.68M |
| EBITDA | 110.43M | 135.54M | 164.50M | 90.04M |
| Interest Expense | 68.26M | 57.36M | 43.96M | 39.43M |
| Pretax Income | -6.83M | 29.09M | 69.01M | -1.41M |
| Tax Provision | -2.50M | 58.34M | 15.70M | 3.50M |
| Net Income | -4.32M | -29.26M | 53.31M | -4.91M |
| Diluted EPS | -0.01 | -0.07 | 0.13 | -0.01 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 424.50M | 742.99M | 1.60B |
| Cost of Revenue | 230.48M | 411.85M | 843.01M |
| Gross Profit | 194.02M | 331.14M | 758.06M |
| Operating Expenses | 139.70M | 228.55M | 650.15M |
| Operating Income | 54.32M | 102.59M | 107.91M |
| EBITDA | 120.49M | 204.35M | 313.98M |
| Interest Expense | 124.50M | 161.05M | 178.51M |
| Pretax Income | -69.33M | -53.00M | -64.64M |
| Tax Provision | -9.41M | 2.47M | -14.81M |
| Net Income | -59.92M | -55.47M | -49.83M |
| Diluted EPS | -0.15 | -0.14 | -0.12 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 6.32B | 6.90B |
| Current Assets | 712.06M | 1.21B |
| Cash & Equivalents | 110.84M | 561.36M |
| Inventory | 301.95M | 315.60M |
| Receivables | 198.96M | 216.94M |
| Total Liabilities | 3.34B | 2.70B |
| Current Liabilities | 263.02M | 240.09M |
| Long Term Debt | 2.51B | 1.88B |
| Total Debt | 2.59B | 1.96B |
| Total Equity | 2.98B | 4.20B |
| Shares Outstanding | 404.33M | 404.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -7.92M | 70.95M | 251.20M |
| Investing Cash Flow | -12.19M | -35.28M | -192.82M |
| Financing Cash Flow | 15.58M | 62.23M | 78.11M |
| Capital Expenditure | -12.50M | -28.89M | -42.42M |
| Free Cash Flow | -20.42M | 42.06M | 208.77M |
| Net Change in Cash | -4.53M | 97.90M | 136.48M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 45.7% | 44.6% | 47.3% |
| Operating Margin % | 12.8% | 13.8% | 6.7% |
| Net Margin % | -14.1% | -7.5% | -3.1% |
| ROE % | - | -1.9% | -1.2% |
| ROCE % | - | 1.7% | 1.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ARXS
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE5EalN2TXFzc202RmVqc3RkWjhSdUhpNzlEUGh2SWpHZjFESGxnbGhqNTBPdmxBUnFTRk1Fb1N0RVlHVDkxN1pzbldCQ2hJUGYt?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Top Arxis (ARXS) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNZ3NxSjA2enF3a0ZTdjRPOUpYeGdqRGM0akExWHZDYk8tU1Ryblo4YXVCQWZQRl8xZUhnNWdZcmV0dzJxbjBFTWlPTFVwUWR6b0NIU0xOUkNQWmZvdnU0UFl0SGxQaFplMXBhX2ZfclI2ZXJnaVNSSldKVS1uS042Sg?oc=5" target="_…
A Look At Arxis (ARXS) Valuation After A Small Share Price Move - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOc3l3a2h6eTBueEVDa2ltSEdSQzR1aHhmN21BVlF0UzhxcVU0SHd2bWJlT1Y1Q1Bfd1A2U1pjMlBEWVJhYUNUYk1fSW1qUnBIcUQ1OGVXaTIwNGRjYkFYSW1sbUFEdkNqWXR6N3BaZHBfRnVGeWh6eFlyWG4wTjEzQkZNYk11MzBNaG04TX…
$ARXS stock is up 17% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNWTZINGFUc05iT2x2eWt6QlRtZDdNcnNuZEZKQnd2dThncVg2dExoeGFvYjdXbnp2cnhhMU1vVnZqS0ZHdmZIRUhvV2lVUk1xV0ZLRnJ4VUJiZlVXVHU5TjBQaTZrU0RaTXdtYUp4M21kdnJDNUxTUUxERGxGcWg4UjZFSE1TSHBJQ05mTH…
ARXS Jumps As Traders Focus On Strong Cash And Momentum - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5EYlY1SHhtb2ZtcEJyVFl5dFNtbl9LWmhFd0xESHZmQTctRWVpclNEeUl6dmlkSmlYSS1hdG5Fa1NQSEVsenFuVEJOOE9SY2RBZkpMY2NnaUNDQzdNWm1PcjBCWmVPLTl2NEVvZ1RB?oc=5" target="_blank">ARXS Jumps As Trade…
Arxis (NASDAQ: ARXS) lifts Q2 revenue 25% and repays $946M of term debt - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPYjNpWWk2RWxEb3drbG9PV2U0cDBWSndnWWxic09EV3BWdFZiT2dWM0ktZ3lHMGpfMW82LWd5Ym5FdnpSNXZGdE9ValpKOGVHc0VtaGdESFlxTkxTdlZiM1JVdWlKWk5HdG96VFRSWGZpeFZtcVVWWnhkN1poN2hKNjdYVkxteWptQjJTQm…
ARXS — Frequently Asked Questions
What is the current share price of ARXS?
As of 2026-08-05 17:25 PDT, ARXS trades at $59.60 on NASDAQ/NYSE. Its 52-week range is $34.05 to $59.60.
What is the market capitalisation of ARXS?
ARXS has a market capitalisation of $24.10B on NASDAQ/NYSE.
What is the P/E ratio of ARXS?
ARXS trades at a trailing price-to-earnings (P/E) ratio of -496.67. Its price-to-book (P/B) ratio is 5.74.
What is the return on equity (ROE) of ARXS?
ARXS has a return on equity (ROE) of -1.19%. Its return on capital employed (ROCE) is 1.62%.
Is ARXS a good stock to buy?
This page provides a data-driven analysis of ARXS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.